Antares Faces Records Suit Over Testosterone Drug Troubles
By Vince Sullivan ( January 30, 2019, 3:54 PM EST) -- A regulatory smackdown dealt to Antares Pharma Inc. over a new injectable testosterone treatment led a shareholder to file a books and records suit in Delaware Chancery Court on Wednesday with the goal of investigating alleged misstatements about the drug's clinical trials....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.